TRB at ISIAT 2025 in Bucharest – Advancing Joint Health Together

From October 2–4, 2025, we’ll be exhibiting at the 8th International Symposium on Intra‑Articular Treatment (ISIAT), held at the Pullman Bucharest World Trade Center. This biennial congress unites international experts in intra‑articular therapies for musculoskeletal disorders. At Booth E, the #TRBTeam is eager to discuss our products in joint-focused treatments for orthopedics and rheumatology specialties.

The symposium program features dynamic consensus updates from EUROVISCO, GRIIP, ESCEO and other leading guideline groups—including discussions on PRP, viscosupplementation, and orthobiologics in osteoarthritis treatment. Attendees can also join hands‑on ultrasound‑guided injection workshops spanning ankle, knee, hip, shoulder, hand/wrist and facet joints, led by expert faculty to refine technical skills.

Key scientific sessions include:

• Comparisons of intra‑articular products, such as adipose‑derived microfragmented fat vs. leukocyte‑poor PRP and hyaluronic acid, and bone‑marrow concentrate (BMAC) vs. adipose‑derived cell suspensions (ADCS) in knee osteoarthritis.
• Predictors of treatment response, exploring how patient demographics and disease stage influence outcomes with PRP and HA therapies.
• Bio‑toxicity studies examining chondrotoxicity of injection products, updated protocols for orthobiologics, and new emerging injectables.
• Athlete‑focused content on intra‑articular interventions for trauma recovery, optimal timing for IA injections in high‑level sport, and functional outcomes research.

These sessions underscore ISIAT’s role as a platform for advancing translational science and driving clinical innovation in musculoskeletal care.

We look forward to connecting with orthopedic surgeons and rheumatologists at Booth E to exchange evidence‑based insights on improving patient outcomes through our latest advances in musculoskeletal treatments.

Find out more